03:21 AM EDT, 10/03/2025 (MT Newswires) -- Joseph Baroldi, Executive Vice President, Chief Business Officer, on October 02, 2025, sold 15,000 shares in Ionis Pharmaceuticals ( IONS ) for $1,020,210. Following the Form 4 filing with the SEC, Baroldi has control over a total of 34,997 common shares of the company, with 31,926 shares held directly and 3,071 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/874015/000087401525000243/xslF345X05/edgardoc.xml